These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33185874)

  • 1. Experimental Methods for the Immunological Characterization of Paradoxical Psoriasis Reactions Induced by TNF-α Biologics.
    Morelli M; Scarponi C; Madonna S; Albanesi C
    Methods Mol Biol; 2021; 2248():155-165. PubMed ID: 33185874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development.
    Fania L; Morelli M; Scarponi C; Mercurio L; Scopelliti F; Cattani C; Scaglione GL; Tonanzi T; Pilla MA; Pagnanelli G; Mazzanti C; Girolomoni G; Cavani A; Madonna S; Albanesi C
    J Pathol Clin Res; 2020 Jan; 6(1):55-68. PubMed ID: 31577850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.
    Morelli M; Carbone ML; Scaglione GL; Scarponi C; Di Francesco V; Pallotta S; De Galitiis F; Rahimi S; Madonna S; Failla CM; Albanesi C
    Front Immunol; 2024; 15():1346687. PubMed ID: 38495872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?
    Lu J; Lu Y
    J Transl Autoimmun; 2023 Dec; 7():100211. PubMed ID: 37731549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
    Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
    World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis.
    Conrad C; Di Domizio J; Mylonas A; Belkhodja C; Demaria O; Navarini AA; Lapointe AK; French LE; Vernez M; Gilliet M
    Nat Commun; 2018 Jan; 9(1):25. PubMed ID: 29295985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
    Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
    Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of paradoxical psoriasiform reactions during TNF- α therapy.
    Navarro R; Daudén E
    Actas Dermosifiliogr; 2014 Oct; 105(8):752-61. PubMed ID: 23938073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.
    Albanesi C; Scarponi C; Bosisio D; Sozzani S; Girolomoni G
    Autoimmunity; 2010 Apr; 43(3):215-9. PubMed ID: 20166874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol.
    Suzuki T; Tatsuno K; Ito T; Sakabe JI; Funakoshi A; Tokura Y
    J Dermatol Sci; 2016 Oct; 84(1):71-79. PubMed ID: 27342039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
    Puig L
    Curr Probl Dermatol; 2018; 53():49-63. PubMed ID: 29131037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents.
    Navarro R; Delgado-Jiménez Y; Guinea-Viniegra J; Llamas-Velasco M; Daudén E
    J Cutan Pathol; 2022 Feb; 49(2):116-122. PubMed ID: 34322902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
    Nestle FO; Conrad C; Tun-Kyi A; Homey B; Gombert M; Boyman O; Burg G; Liu YJ; Gilliet M
    J Exp Med; 2005 Jul; 202(1):135-43. PubMed ID: 15998792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration.
    Gschwandtner M; Mommert S; Köther B; Werfel T; Gutzmer R
    J Invest Dermatol; 2011 Aug; 131(8):1668-76. PubMed ID: 21614010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
    George LA; Gadani A; Cross RK; Jambaulikar G; Ghazi LJ
    Dig Dis Sci; 2015 Nov; 60(11):3424-30. PubMed ID: 26115749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.